Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD

被引：0
|
作者：
Fiore, F.
Patti, K.
Viviani, S.
Rossi, A.
Di Raimondo, F.
Cantonetti, M.
Feldman, T.
Biggi, A.
Barrington, S.
Gallamini, A.
机构：
[1] S Croce Mem Hosp, Dept Hematol, Cuneo, Italy
[2] V Cervello Hosp, Dept Hematol, Palermo, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[4] Osped Riuniti Bergamo, Dept Hematol, Bergamo, Italy
[5] Univ Catania, Dept Hematol, Catania, Italy
[6] Univ Roma Tor Vergata, Dept Hematol, Rome, Italy
[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[8] S Croce Gen Hosp, Dept Nucl Med, Cuneo, Italy
[9] Kings Coll London, PET Imaging Ctr St Thomas, Div Imaging, London WC2R 2LS, England
[10] S Croce Gen Hosp, Dept Hematol, Cuneo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8006
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Early interim FDG-PET overshadows the prognostic role of IPS in advanced-stage Hodgkin lymphoma treated by conventional ABVD therapy
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Vitolo, U.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 32 - 32
  • [22] Cost-Effectiveness of Interim PET Response Adapted Therapy In ABVD-Treated, Advanced-Stage Hodgkin Lymphoma
    Gallamini, Andrea
    Marchetti, Monia
    Borra, Anna
    Sorasio, Roberto
    Fiore, Francesca
    BLOOD, 2011, 118 (21) : 679 - 680
  • [23] Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
    Gallamini, Andrea
    Tarella, Corrado
    Viviani, Simonetta
    Rossi, Andrea
    Patti, Caterina
    Mule, Antonino
    Picardi, Marco
    Romano, Alessandra
    Cantonetti, Maria
    La Nasa, Giorgio
    Trentin, Livio
    Bolis, Silvia
    Rapezzi, Davide
    Battistini, Roberta
    Gottardi, Daniela
    Gavarotti, Paolo
    Corradini, Paolo
    Cimminiello, Michele
    Schiavotto, Corrado
    Parvis, Guido
    Zanotti, Roberta
    Gini, Guido
    Ferreri, Andres J. M.
    Viero, Piera
    Miglino, Maurizio
    Billio, Atto
    Avigdor, Abraham
    Biggi, Alberto
    Fallanca, Federico
    Ficola, Umberto
    Gregianin, Michele
    Chiaravalloti, Agostino
    Prosperini, Giuseppe
    Bergesio, Fabrizio
    Chauvie, Stephane
    Pavoni, Chiara
    Gianni, Alessandro Massimo
    Rambaldi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05) : 454 - +
  • [24] High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan
    Kedmi, Meirav
    Apel, Arie
    Davidson, Tima
    Levi, Itai
    Dann, Eldad J.
    Polliack, Aaron
    Ben-Bassat, Isaac
    Nagler, Arnon
    Avigdor, Abraham
    ACTA HAEMATOLOGICA, 2016, 135 (03) : 156 - 161
  • [25] TAILORED THERAPY FOR ADVANCED-STAGE HODGKIN LYMPHOMA, GUIDED BY INTERIM 18FDG-PET, WITH BEACOPP-ESCALATED FOLLOWED BY ABVD REGIMEN DECREASES REFRACTORY DISEASE RATES
    Amutio, E.
    Del Orbe, R. A.
    Amarika, I.
    Landeta, E.
    Zamora, M. E.
    Puente, M.
    Iglesias-Perez, A. M.
    Olazabal, I.
    Duenas, M.
    Balerdi, A.
    Elicegui, L.
    Arambarri, S.
    Garcia-Ruiz, J. C.
    HAEMATOLOGICA, 2014, 99 : 676 - 677
  • [26] Interim-PET Scan Interpretation In the Ongoing Prospective Clinical Trial HD 0607, In Advanced-Stage Hodgkin Lymphoma: Results of the the Expert Panel Review
    Gallamini, Andrea
    Biggi, Alberto
    Chauvie, Stephane
    Stancu, Alexandru
    Fallanca, Federico
    Chiaravalloti, Agostino
    Gregianin, Michele
    Ficola, Umberto
    Guerra, Ugo
    Mennitto, Maria Rosaria
    Rambaldi, Alessandro
    BLOOD, 2010, 116 (21) : 1589 - 1589
  • [27] Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
    Skoetz, Nicole
    Will, Andrea
    Monsef, Ina
    Brillant, Corinne
    Engert, Andreas
    von Tresckow, Bastian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (05):
  • [28] EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Zikavska, L.
    Vernerova, Z.
    Klaskova, K.
    Dedeckova, K.
    Eich, H. T.
    Dietlein, M.
    Fuchs, M.
    Engert, A.
    Kozak, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 33 - 33
  • [29] International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
    Biggi, Alberto
    Gallamini, Andrea
    Chauvie, Stephane
    Hutchings, Martin
    Kostakoglu, Lale
    Gregianin, Michele
    Meignan, Michel
    Malkowski, Bogdan
    Hofman, Michael S.
    Barrington, Sally F.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) : 683 - 690
  • [30] Predictive Value of Interim 18FDG-PET on Treatment Outcome in Advanced-Stage Hodgkin's Disease
    Castagnoli, A.
    Rigacci, L.
    Versari, A.
    Gallamini, A.
    Matteini, M.
    Merli, F.
    Nassi, L.
    Peano, S.
    Pelosi, E.
    Gregianin, M.
    Vaggelli, L.
    Levis, A.
    Biggi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S24 - S24
12345